Interplay between SARS-CoV-2 and the type I interferon response - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue PLoS Pathogens Année : 2020

Interplay between SARS-CoV-2 and the type I interferon response

Résumé

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the current COVID-19 pandemic. An unbalanced immune response, characterized by a weak production of type I interferons (IFN-Is) and an exacerbated release of proinflammatory cytokines, contributes to the severe forms of the disease. SARS-CoV-2 is genetically related to SARS-CoV and Middle East respiratory syndrome-related coronavirus (MERS-CoV), which caused outbreaks in 2003 and 2013, respectively. Although IFN treatment gave some encouraging results against SARS-CoV and MERS-CoV in animal models, its potential as a therapeutic against COVID-19 awaits validation. Here, we describe our current knowledge of the complex interplay between SARS-CoV-2 infection and the IFN system, highlighting some of the gaps that need to be filled for a better understanding of the underlying molecular mechanisms. In addition to the conserved IFN evasion strategies that are likely shared with SARS-CoV and MERS-CoV, novel counteraction mechanisms are being discovered in SARS-CoV-2-infected cells. Since the last coronavirus epidemic, we have made considerable progress in understanding the IFN-I response, including its spatiotemporal regulation and the prominent role of plasmacytoid dendritic cells (pDCs), which are the main IFN-I-producing cells. While awaiting the results of the many clinical trials that are evaluating the efficacy of IFN-I alone or in combination with antiviral molecules, we discuss the potential benefits of a well-timed IFN-I treatment and propose strategies to boost pDC-mediated IFN responses during the early stages of viral infection.
Fichier principal
Vignette du fichier
journal.ppat.1008737.pdf (1.37 Mo) Télécharger le fichier
Origine Publication financée par une institution
Loading...

Dates et versions

inserm-02965704 , version 1 (13-10-2020)

Licence

Identifiants

Citer

Margarida Sa Ribero, Nolwenn Jouvenet, Marlène Dreux, Sébastien Nisole. Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathogens, 2020, 16 (7), pp.e1008737. ⟨10.1371/journal.ppat.1008737⟩. ⟨inserm-02965704⟩
307 Consultations
719 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More